Fort Point Capital Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Fort Point Capital Partners's VRTX Position: Q2 2026 in Review
Fort Point Capital Partners increased its Vertex Pharmaceuticals (VRTX) stake by 112% in Q2 2026, buying an estimated $295K and bringing the position to 1,259 shares worth $596K. The position accounts for 0.04% of the portfolio, ranked #155.
Fort Point Capital Partners first reported a position in VRTX in Q4 2023 and has held it in 11 quarters since. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Fort Point Capital Partners held 1,259 shares of Vertex Pharmaceuticals worth $596K as of Q2 2026.
- Fort Point Capital Partners bought 666 Vertex Pharmaceuticals shares in Q2 2026, an estimated $295K.
- Vertex Pharmaceuticals made up 0.04% of Fort Point Capital Partners's portfolio in Q2 2026, its #155 holding.
- Fort Point Capital Partners first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
- 1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Fort Point Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.